Miller TP - Search Results

1

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.

Von Hoff DD, Green S, Alberts DS, Stock-Novack DL, Surwit EA, Miller TP, Stephens RL. Von Hoff DD, et al. Among authors: miller tp. Am J Clin Oncol. 1991 Jun;14(3):193-4. doi: 10.1097/00000421-199106000-00004. Am J Clin Oncol. 1991. PMID: 1709556 Clinical Trial.

2

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study.

Miller TP, Chen TT, Coltman CA Jr, O'Bryan RM, Vance RB, Weiss GB, Fletcher WS, Stephens RL, Livingston RB. Miller TP, et al. J Clin Oncol. 1986 Apr;4(4):502-8. doi: 10.1200/JCO.1986.4.4.502. J Clin Oncol. 1986. PMID: 3007683 Clinical Trial.

3

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study.

Taylor CW, Crowley J, Williamson SK, Miller TP, Taylor SA, Giri TG, Stephens RL, Livingston RB. Taylor CW, et al. Among authors: miller tp. J Clin Oncol. 1990 Nov;8(11):1811-7. doi: 10.1200/JCO.1990.8.11.1811. J Clin Oncol. 1990. PMID: 2172473

4

Phase II trial of bisantrene in non-small cell lung cancer.

Miller TP, Ahmann FR, Mackel C, Greenberg BR, Alberts DS. Miller TP, et al. Invest New Drugs. 1985;3(4):393-5. doi: 10.1007/BF00170764. Invest New Drugs. 1985. PMID: 4086247

5

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group study.

Atiba JO, Green SJ, Hynes HE, Osborne CK, Miller TP, Davidner M. Atiba JO, et al. Among authors: miller tp. Invest New Drugs. 1994;12(2):129-32. doi: 10.1007/BF00874442. Invest New Drugs. 1994. PMID: 7860229 Clinical Trial.

6

Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas.

Miller TP, Jones SE, Alberts DS, Mackel C. Miller TP, et al. Invest New Drugs. 1984;2(1):75-7. doi: 10.1007/BF00173790. Invest New Drugs. 1984. PMID: 6469502

7

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.

Miller TP, Dahlberg S, Weick JK, Files JC, Eyre HJ, Pendergrass KB, Fisher RI. Miller TP, et al. J Clin Oncol. 1990 Dec;8(12):1951-8. doi: 10.1200/JCO.1990.8.12.1951. J Clin Oncol. 1990. PMID: 1700079 Clinical Trial.

8

Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.

Braich TA, Salmon SE, Robertone A, Alberts DS, Jones SE, Miller TP, Garewal HS. Braich TA, et al. Among authors: miller tp. Invest New Drugs. 1986;4(3):269-74. doi: 10.1007/BF00179595. Invest New Drugs. 1986. PMID: 3818231

9

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

Velasquez WS, Lew D, Grogan TM, Spiridonidis CH, Balcerzak SP, Dakhil SR, Miller TP, Lanier KS, Chapman RA, Fisher RI; Southwest Oncology Group. Velasquez WS, et al. Among authors: miller tp. J Clin Oncol. 2003 May 15;21(10):1996-2003. doi: 10.1200/JCO.2003.09.047. J Clin Oncol. 2003. PMID: 12743154 Clinical Trial.

10

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.

Ludwig R, Alberts DS, Miller TP, Salmon SE. Ludwig R, et al. Among authors: miller tp. Cancer Chemother Pharmacol. 1984;12(3):135-41. doi: 10.1007/BF00256533. Cancer Chemother Pharmacol. 1984. PMID: 6705130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters